Is CVE-2023-26089 actively exploited?

No active exploitation of CVE-2023-26089 has been confirmed so far. Continue monitoring, as exploit status can change.

Can CVE-2023-26089 be exploited remotely?

Yes. CVE-2023-26089 is exploitable remotely over the network (CVSS attack vector: Network).

What is the CVSS score of CVE-2023-26089?

CVE-2023-26089 has a CVSS score of 9.8 (CRITICAL).

HOME VULNERABILITIESCVE-2023-26089

CRITICAL

CVE-2023-26089

CWE-798Published: May 2, 2023· Updated: Jun 17, 2026

9.8

CVSS v3.1

Official Description

European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.

NVD Source

Risk Analysis

IUCLID 6.x is vulnerable to an authentication bypass due to the use of a hard-coded secret for JWT signing. This critical flaw allows attackers to bypass security controls, warranting immediate attention due to its 9.8 CVSS score.

No public exploit is currently known for this remotely exploitable vulnerability.

Recommended Action

Upgrade to IUCLID version 6.27.6 or later to resolve the authentication bypass.

Generated by the CTIWATCH analysis pipeline from this CVE's metadata (CVSS, EPSS, KEV status, exploit intelligence). Verify against vendor advisories before acting.

Technical Analysis

CVE-2023-26089 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 9.8.